Literature DB >> 28483190

Acupuncture Treatment of Diabetic Peripheral Neuropathy in an American Indian Community.

Anne Bailey1, Deborah Wingard2, Matthew Allison2, Priscilla Summers3, Daniel Calac3.   

Abstract

Diabetic peripheral neuropathy (DPN) develops in 30% of type 2 diabetes patients, increases the risk for foot ulcers and amputation, and is a significant source of disability and medical costs. Treatment remains challenging, propelling research to focus on therapeutic methods that aim to improve blood circulation or ameliorate oxidative stress that drives development of DPN. The aim of this study was to assess the effectiveness of acupuncture treatment for DPN symptoms and lower extremity arterial circulation in people with type 2 diabetes. Twenty-five patients seen at a Southern California Tribal Health Center who reported a threshold level of diabetic neuropathy symptoms in the lower extremities during the previous 4 weeks received acupuncture treatment once per week over a 10-week period between 2011 and 2013. The Neuropathy Total Symptom Scale (NTSS-6), Neuropathy Disability Score (NDS), and laser Doppler fluxmetry (LDF) were used for assessment at baseline and 10 weeks. A total of 19 of 25 study participants completed the study and reported a significant reduction in the NTSS symptoms of aching pain, burning pain, prickling sensation, numbness, and allodynia. Lancinating pain did not decrease significantly. LDF measures improved but not significantly. Acupuncture may effectively ameliorate selected DPN symptoms in these American Indian patients.
Copyright © 2017 Medical Association of Pharmacopuncture Institute. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  acupuncture; diabetic peripheral neuropathy; laser Doppler fluxmetry; nitric oxide

Mesh:

Year:  2016        PMID: 28483190     DOI: 10.1016/j.jams.2016.10.004

Source DB:  PubMed          Journal:  J Acupunct Meridian Stud        ISSN: 2005-2901


  8 in total

Review 1.  Current Strategies for the Management of Painful Diabetic Neuropathy.

Authors:  Michael D Staudt; Tarun Prabhala; Breanna L Sheldon; Nicholas Quaranta; Michael Zakher; Ravneet Bhullar; Julie G Pilitsis; Charles E Argoff
Journal:  J Diabetes Sci Technol       Date:  2020-08-28

2.  Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain.

Authors:  W Iris Zhi; Evan Ingram; Susan Qing Li; Patricia Chen; Lauren Piulson; Ting Bao
Journal:  Integr Cancer Ther       Date:  2018-07-20       Impact factor: 3.279

3.  Effectiveness of acupuncture for treatment of diabetic peripheral neuropathy.

Authors:  You-Jie Zhang; Fan-Rong Liu
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

4.  Acupuncture methods for diabetic peripheral neuropathy: A protocol for a Bayesian network meta-analysis.

Authors:  Hai Lun Jiang; Qiang Zhang; Yu Zheng Du; Xiang Gang Meng; Hai Peng Ban; Yang Tao Lu
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

Review 5.  Adjuvant Therapy With Mushroom Polysaccharides for Diabetic Complications.

Authors:  Xue Jiang; Weiqi Meng; Lanzhou Li; Zhaoli Meng; Di Wang
Journal:  Front Pharmacol       Date:  2020-02-28       Impact factor: 5.810

6.  Acupuncture for diabetic peripheral neuropathy: study protocol for a randomized, placebo-controlled trial.

Authors:  Haiping Deng; Yu Shu; Peiran Lv; Ling Zhao; Ke Cheng; Tingting Zhang; Yi Song; Hua Yang; Hong Tang; Jian Pei; Xueyong Shen
Journal:  Trials       Date:  2020-10-26       Impact factor: 2.279

7.  Acupuncture as adjuvant therapy for diabetic foot: A protocol for systematic review.

Authors:  Maosheng Lee; Huilin Li; Deliang Liu
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

8.  Proteomics Analysis of the Spinal Dorsal Horn in Diabetic Painful Neuropathy Rats With Electroacupuncture Treatment.

Authors:  Xiangmei Yu; Xiaomei Chen; Weiting Liu; Menghong Jiang; Zhifu Wang; Jing Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.